UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 9.

Wittkop, L; Günthard, H F; de Wolf, F; Dunn, D; Cozzi-Lepri, A; de Luca, A; Kücherer, C; Obel, N; von Wyl, V; Masquelier, B; Stephan, C; Torti, C; Antinori, A; García, F; Judd, A; Porter, K; Thiébaut, R; Castro, H; van Sighem, A I; Colin, C; Kjaer, J; Lundgren, J D; Paredes, R; Pozniak, A; Clotet, B; Phillips, A; Pillay, D; Chêne, G (2011). Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infectious Diseases, 11(5):363-371.

Jentzmik, F; Stephan, C; Lein, M; Miller, K; Kamlage, B; Bethan, B; Kristiansen, G; Jung, K (2011). Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression. The Journal of Urology, 185(2):706-711.

Gerhardt, J; Steinbrech, C; Büchi, O; Behnke, S; Bohnert, A; Fritzsche, F; Liewen, H; Stenner, F; Wild, P; Hermanns, T; Müntener, M; Dietel, M; Jung, K; Stephan, C; Kristiansen, G (2011). The androgen-regulated Calcium-Activated Nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro. American Journal of Pathology, 178(4):1847-1860.

Schaefer, A; Jung, M; Kristiansen, G; Lein, M; Schrader, M; Miller, K; Stephan, C; Jung, K (2010). MicroRNAs and cancer: current state and future perspectives in urologic oncology. Urologic Oncology, 28(1):4-13.

Tischler, V; Fritzsche, F R; Wild, P J; Stephan, C; Seifert, H H; Riener, M O; Hermanns, T; Mortezavi, A; Gerhardt, J; Schraml, P; Jung, K; Moch, H; Soltermann, A; Kristiansen, G (2010). Periostin is up-regulated in high grade and high stage prostate cancer. BMC Cancer, 10:273.

Esgueva, R; Perner, S; Lafargue, C J; Scheble, V; Stephan, C; Lein, M; Fritzsche, F R; Dietel, M; Kristiansen, G; Rubin, M A (2010). Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort. Modern Pathology, (23):539-546.

Schaefer, A; Jung, M; Kristiansen, G; Lein, M; Schrader, M; Miller, K; Erbersdobler, A; Stephan, C; Jung, K (2009). Mikro-RNA in der Uroonkologie. Neue Hoffnungen für die Diagnostik und Therapie von Tumoren? Der Urologe. Ausg. A, 48(8):877-885.

Kristiansen, G; Fritzsche, F R; Wassermann, K; Jäger, C; Tölle, A; Lein, M; Stephan, C; Jung, K; Pilarsky, C; Dietel, M; Moch, H (2008). GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. British Journal of Cancer, 99(6):939-948.

Weichert, W; Röske, A; Gekeler, V; Beckers, T; Stephan, C; Jung, K; Fritzsche, F R; Niesporek, S; Denkert, C; Dietel, M; Kristiansen, G (2008). Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. British Journal of Cancer, 98(3):604-610.

This list was generated on Thu Jul 27 17:04:15 2017 CEST.